http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
임신과 합병된 재생 불량성 빈혈환자 37예에 대한 임상적 고찰
이근호(Keun Ho Lee),이종건(Jong Kun Lee),류진희(Jin Hee Yoo),이지현(Jee Hyun Lee),조형권(Hyeong Kwon Jo),이지영(Ji Young Lee),김승조(Seung Jo Kim),김수평(Soo Pyung Kim) 대한산부인과학회 1999 Obstetrics & Gynecology Science Vol.42 No.11
Objectives: To determine whether the clinical aspect of aplastic anemia is influenced by pregnancy. Methods: We reviewed 37 cases of pregnant aplastic anemia patients during Jan. 1989 to Dec. 1998, and examined age, parity, progress of pregnancy, termination methods, obstetrics & neonatal complications, hematologic change, and treatment modality by medical records. Results: According to onset of disease, patients were divided into pre-pregnant diagnosed group(n=12) and during-pregnancy diagnosed group(n=25). Mean age of diagnosis was 29.4yr, 89.2% were nulliparous, and 51.4% were severe aplastic anemic patients. All patients underwent 50 pregnancy. Mean gestational period was 37wks, birth weight was 2569gram, and, except in 7 cases of abortion, 43 cases were delivered transvaginally or transabdominally(51.2% vs. 48.8%). Preeclampsia, eclampsia, preterm labor, restricted growth, and distress were complicated and decreased hemoglobin, hematocrit, reticulocyte, platelet were reversed after termination in pregnancy associated group. Treatment modality during pregnancy included transfusion, steroid, anti-lymphocytic globulin, anti-thymocytic globulin and IVGV, and remission rate was 45.5% in pregnancy associated group. Conclusion: We concluded that pregnancy is associated with aplastic anemia as a high risk factor, and intensive treatment is needed.
자궁경부암 세포의 증식에 관여하는 annexin-I의 역할
유영옥(Young Ok Lew),박태철(Tae Chul Park),남궁성은(Sung Eun NamKoong),박동춘(Dong Choon Park),김재훈(Jae Hoon Kim),김대훈(Dae Hoon Kim),양용재(Yong Jae Yang),이지현(Jee Hyun Lee),조성대(Sung Dae Cho),조형권(Hyeong Kwon Jo) 대한산부인과학회 1999 Obstetrics & Gynecology Science Vol.42 No.10
Objectives: To investigate the role of annexin-I in human cervical cancer, we evaluated the expression of annexin-I and the relation with the proliferation of cancer cells. Methods: By immunohistochemical analysis and the western blotting of annexin-I , we investigated the extent and distribution of the expression of annexin-I in cervical cancer tissues. After treating the human cancer cell lines ( SiHa and HeLa cell lines ) with tamoxifen, estradiol, and retinoic acid for 5 days to make the cells proliferate and antiproliferate, we measured the proliferation simultaneously with 3-(4,5- dimethyl thiazol- 2-yl)-2,5-diphenyl-tetr -azolium bromide (MTT) colorimetric assay and the expression level of annexin-I with flowcytometry. Results: In the immunohistochemical stains, a granular staining pattern involving the entire cytoplasm was more heavily observed in malignant lesions than in normals. In the western blotting, the antibodies against 35-kDa annexin-I appeared to react more strongly with the lysates of cancer tissues than normal and benign tissues. In SiHa and HeLa cell lines with tamoxifen and β- estradiol treatment, increased expressions of annexin-I were noted with correlated increased proliferation of cells, and with the treatments of all trans retinoic acid, decreased expressions of annexin-I were noted with correlated decreased proliferation of cells. Conclusions: The results suggest that the expression of annexin-I might correlate with cervical cancer than normal and the proliferation of cancer cells.